Loading company details...
Beta
Latest Form 4 (Sep 14, 2026): David P. Meeker (President and CEO): Exercise/Conversion of 50,000 shares, $302.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | David P. Meeker, President and CEO | Exercise/Conversion | 50,000 | $302.5K |
| Sep 1, 2026 | Hunter C. Smith, Chief Financial Officer | Exercise/Conversion | 57,187 | $1.47M |
| Aug 18, 2026 | Manher Joshi, Chief Medical Officer | Grant/Award | 50,000 | n/a |
| Aug 17, 2026 | Joseph Shulman, Chief Technical Officer | Exercise/Conversion | 2,024 | $13.8K |
| Aug 17, 2026 | Alastair Garfield, Chief Scientific Officer | Sale | 2,007 | $233.0K |
| Aug 14, 2026 | Jennifer Kayden Lee, EVP, Head of North America | Exercise/Conversion | 35,000 | $850.1K |
| Aug 14, 2026 | Yann Mazabraud, EVP, Head of International | Exercise/Conversion | 46,625 | $317.1K |
| Jul 2, 2026 | Alastair Garfield, Chief Scientific Officer | Exercise/Conversion | 4,445 | n/a |
| Jun 25, 2026 | Christophe Jean | Exercise/Conversion | 4,712 | n/a |
| Jun 25, 2026 | David W. J. Mcgirr | Exercise/Conversion | 4,712 | n/a |